25 results on '"Alberts S.R."'
Search Results
2. Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]
3. Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)
4. Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
5. Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
6. Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
7. Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population
8. Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†
9. 391MO Impact of diabetes and metformin use on recurrence and outcome in early colon cancer (CC) patients: A pooled analysis of 3 adjuvant trials
10. Genetically predicted circulating c-reactive protein concentration and colorectal cancer survival: A mendelian randomization consortium study.
11. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study
12. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
13. PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study
14. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
15. Gastric cancer: epidemiology, pathology and treatment
16. Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study
17. Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
18. A phase I study of sequential irinotecan and5-fluorouracil/leucovorin
19. Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study
20. Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks
21. Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566
22. Outcome of Transplant Fallout Patients With Unresectable Cholangiocarcinoma
23. 395 SURVIVAL OF PATIENTS RECEIVING YTTRIUM-90 MICROSPHERES VS CHEMOEMBOLIZATION FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
24. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
25. Neoadjuvant radiotherapy and liver transplantation for perihilar cholangiocarcinoma: a thirty-year experience with long-term survival.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.